...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Bear
2
Apr 16, 2018 08:56AM
2
Apr 16, 2018 01:24PM

Apr 16, 2018 04:24PM

Actually I think it is the company’s responsibility to update their info. RVX still has Mar 15, 2018 as the anticipated start date for the study with those on hemodialysis. I think they missed it.......

2
Apr 17, 2018 02:08AM
1
Apr 17, 2018 01:35PM
1
Apr 17, 2018 03:32PM

Apr 17, 2018 05:13PM
Share
New Message
Please login to post a reply